FER-IN-SOL DROPS OTC
Generic Name and Formulations:
Iron 15mg/1mL (as sulfate 75mg/1mL); contains sulfites, alcohol; gluten-free.
Mead Johnson Nutrition
- Biomarker Detects Early Stage Lung Cancer
- How to Minimize Radiation Exposure in Thyroid Cancer Care
- CRC Incidence Continues to Decrease Among Adults
- Children's Vitamins Clinical Chart
- Allergic Conjunctivitis Drug Treatments
- Bacterial Conjunctivitis Drug Treatments
Indications for FER-IN-SOL DROPS:
Iron deficiency and iron deficiency anemias.
Adults and Children:
May give directly into the mouth or mix with formula, fruit juice, cereal or other foods. <4yrs: 1mL daily. ≥4yrs: not recommended.
Monitor hemoglobin, hematocrit, reticulocyte count periodically. Elderly.
Inhibits tetracycline absorption.
Nausea, abdominal discomfort and pain, constipation, masks occult bleeding, black stools, stains teeth and dentures.
Drops—50mL (w. calibrated dropper)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Model May Identify Patients With Gastric Cancer Likely To Benefit From Chemotherapy